PREVAIL THERAPEUTICS
Live / Registered — Registered (as of 17 Nov 2020)
What this means for you
Registered since 17 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88064247
- Registration number
- 6200943
- Mark type
- Stylized text
- Filed
- 03 Aug 2018
- Published for opposition
- 29 Jan 2019
- Registered
- 17 Nov 2020
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurodegenerative diseases and lysosomal disorders; none of the foregoing for use in treating incontinence
Owner
- Prevail Therapeutics, Inc., New York, NY, US
- Prevail Therapeutics, Inc., New York, NY, US
- Prevail Therapeutics, Inc., New York, NY, US
Prosecution history
- 17 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Mar 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Mar 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Mar 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Mar 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Mar 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Sept 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Sept 2020 — USE AMENDMENT FILED
- 24 Sept 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
- 21 Mar 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Mar 2020 — SOU EXTENSION 2 GRANTED